Add Company
Join Now

Instech Laboratories Revenue and Competitors

License our Company Data API

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Instech Laboratories's estimated annual revenue is currently $7.8M per year.(i)
  • Instech Laboratories's estimated revenue per employee is $155,000

Employee Data

  • Instech Laboratories has 50 Employees.(i)
  • Instech Laboratories grew their employee count by 9% last year.

Instech Laboratories's People

NameTitleEmail/Phone
1
Founder and Chief Technology OfficerReveal Email/Phone
2
VP EngineeringReveal Email/Phone
3
VP SalesReveal Email/Phone
4
VP MarketingReveal Email/Phone
5
VP Human ResourcesReveal Email/Phone
6
Director Mechanical Engineering & ManufacturingReveal Email/Phone
7
IT ManagerReveal Email/Phone
8
Manager, OrchesTA infusionReveal Email/Phone
9
Product Manager, Aqueous SolutionsReveal Email/Phone
10
PresidentReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$1.6M100%N/AN/A
#2
$4M2613%N/AN/A
#3
$0.9M6-14%N/AN/A
#4
$1.1M70%N/AN/A
#5
$10.9M703%N/AN/A
#6
$0.7M929%N/AN/A
#7
$4M26-16%N/AN/A
#8
$1.7M1122%N/AN/A
#9
$7.6M492%N/AN/A
#10
$1.6M100%N/AN/A
Add Company

What Is Instech Laboratories?

Founded in 1971, Instech is a leader in the design and manufacturing of infusion systems for laboratory animal research. Products include swivels, tethers, ports, catheters, feeding needles, infusion pumps and automated blood samplers. Instech also manufactures oxygen monitoring systems and peristaltic pumps. The company manufactures its products in Pennsylvania USA and sells them to customers in North America, Europe and India with a direct salesforce and to customers elsewhere in the world through a network of approved distributors.

keywords:N/A

N/A

Total Funding

50

Number of Employees

$7.8M

Revenue (est)

9%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$10.5M536%N/A
#2
$10.4M556%N/A
#3
$16.8M578%N/A
#4
$12.2M580%N/A
#5
$15.1M587%N/A